Keywords: Merck & Co, Schering-Plough, Second-quarter 2010 financial results

Merck & Co’s 2nd-qtr 2010 profits plunge 52% on S-P buy costs, but still beat expectations

Article | 02 August 2010

Print This

Costs related to its $41 billion acquisition of fellow drug major Schering-Plough last year have eaten into Merck & Co’s ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in